Health
FDA Voucher Program Under Scrutiny
STAT News questions the future of Will Makary’s FDA voucher program, which aims to make cancer drugs more accessible but faces challenges.
Coverage timeline — 1 article
STAT News
RevMed's cancer drug feels out of reach for some, SCOTUS preserves key generic drug pathway, and more biotech news
2026-06-05 13:45 UTC